Market News
Latest news from Stock markets.
Slide Insurance Holdings, Inc. (SLDE) Q1 2026 Earnings Call Transcript
Slide Insurance Holdings, Inc. (SLDE) Q1 2026 Earnings Call Transcript
...keep reeding on seekingalpha.com
888 Holdings plc. (EIHDF) Q4 2025 Earnings Call Transcript
888 Holdings plc. (EIHDF) Q4 2025 Earnings Call Transcript
...keep reeding on seekingalpha.com
Gold market analysis for April 30 - key intra-day price entry levels for active traders
Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.
...keep reeding on kitco.com
MoneyHero Group Reports Unaudited Fourth Quarter and Audited Full Year 2025 Results
SINGAPORE, April 30, 2026 (GLOBE NEWSWIRE) -- MoneyHero Limited (Nasdaq: MNY ) (“MoneyHero” or the “Company”), a leading tech- and AI-powered personal finance aggregation and comparison platform and a digital insurance brokerage provider in Greater Southeast Asia, today announced its financial results for the fourth quarter and full year ended December 31, 2025.
...keep reeding on globenewswire.com
Polymarket and Bitget Wallet Launch Prediction Markets Report, Seeing Rising Retail Activity Reaching $25.7B Monthly Volume
Prediction markets are increasingly becoming a continuous part of how users engage with real-world events, not just a place for one-off event trades.
...keep reeding on globenewswire.com
Best Income Stocks to Buy for April 30th
KFRC, VOD and ARCAY made it to the Zacks Rank #1 (Strong Buy) income stocks list on April 30th, 2026.
...keep reeding on zacks.com
New Strong Sell Stocks for April 30th
AMTB, BX and ACIW have been added to the Zacks Rank #5 (Strong Sell) List on April 30th, 2026.
...keep reeding on zacks.com
Freeport Tanks Again on Mine Delay—Long Term Outlook Stays Strong
For copper mining giant Freeport McMoRan NYSE: FCX, 2025 proved to be a very strong year. The stock delivered a total return of over 35%, marking its best annual performance since 2021.
...keep reeding on marketbeat.com
DavidsTea: Substantial Upside After Impressive Close To FY2025 - Buy
After numerous mediocre quarters, DavidsTea finished fiscal year 2025 on a very strong note, with margins and profitability reaching new multi-year highs. On the conference call, management largely reiterated previously stated growth and profitability targets. While rebuilding the company's Canadian store fleet will require more time and investment, I would expect investors to cheer management's efforts to reinvigorate growth.
...keep reeding on seekingalpha.com
HI-VIEW RESOURCES COMMENCES TRADING ON AMERICA'S OTCQB MARKETPLACE UNDER “GXLDF”
VANCOUVER, BRITISH COLUMBIA, April 30, 2026 (GLOBE NEWSWIRE) -- HI-VIEW RESOURCES INC. (“Hi-View” or the “Company”) (CSE: GXLD; OTCQB: GXLDF; FSE: B630) announces the Company's common shares have commenced trading on the OTCQB Venture Market ("OTCQB") under the symbol “GXLDF”. The OTCQB listing intended to enhance visibility with U.S. investors and improve trading accessibility.
...keep reeding on globenewswire.com
Guardian Metal Resources PLC Announces Total Voting Rights
LONDON, UK / ACCESS Newswire / April 30, 2026 / In accordance with the Financial Conduct Authority's ("FCA") Disclosure and Transparency Rules, the Company hereby announces that as at 30 April 2026 there were 194,307,981 ordinary shares of £0.01 each in issue, none of which are held in treasury. Therefore, the total number of voting rights in the Company is 194,307,981.
...keep reeding on accessnewswire.com
Novo Nordisk: Pricing Pressure And Falling Margins Make This A Value Trap (Q1 Earnings Preview)
Novo Nordisk faces sustained margin compression due to intensifying price competition in the GLP-1 weight loss drug market. Gross profit margin has declined from over 84% to 80%, and profit margin from over 36% to 33%, with further declines expected. Direct-to-consumer programs and the competitive situation have eroded previously robust self-pay margins for NVO's Wegovy.
...keep reeding on seekingalpha.com
Greene Concepts, Inc. Highlights Quality Standards Supporting Consistent Performance of Be Water
MARION, NC / ACCESS Newswire / April 30, 2026 / Greene Concepts, Inc. (OTCID:INKW), owner and operator of a 60,000-square-foot bottling facility in Marion, North Carolina, and producer of the premium artesian spring water brand Be Water™, today highlighted the quality standards and production controls that support product consistency across daily consumer use. Be Water is produced using standardized sourcing, bottling, and quality assurance processes designed to maintain consistent taste, mineral profile, and product integrity.
...keep reeding on accessnewswire.com
Extreme Networks Q3 Earnings Review: A Blowout Quarter, Keep Holding
Extreme Networks delivered a double beat in Q3 '26, with revenues up 11.2% to $316.9M and EPS of $0.26. SaaS ARR accelerated to 29% y/y, with Extreme Platform One adoption driving recurring revenues to 36% of total; EMEA revenue surged 43%. Gross margins remained stable at 61.7% GAAP, while operating margins improved; the Wi-Fi 7 refresh cycle and Platform One adoption are key forward growth drivers.
...keep reeding on seekingalpha.com
Creating America's First Transcontinental Railroad: Union Pacific and Norfolk Southern's Amended STB Merger Application Estimates Shippers Will Save $3.5 Billion Annually
OMAHA, Neb. & ATLANTA--(BUSINESS WIRE)--Union Pacific Corporation (NYSE: UNP) and Norfolk Southern Corporation (NYSE: NSC) today submitted an amended merger application to the Surface Transportation Board (STB) seeking approval to create America's first transcontinental railroad. Additional analysis reinforces that the combination will drive growth, enable substantial cost savings for shippers and strengthen the U.S. supply chain. “After completing the additional work requested by the STB, the.
...keep reeding on businesswire.com
GreenFirst to Host First Quarter 2026 Earnings Call
NORTH BAY, Ontario--(BUSINESS WIRE)--GreenFirst Forest Products Inc. (TSX: GFP) (“GreenFirst” or the “Company”) will host a conference call to review its first quarter of 2026 financial results on Wednesday, May 6, 2026 at 9:00am (Eastern). The results are scheduled to be released at the close of trading on May 5, 2026. The live webcast of the earnings conference call can be accessed via telephone: (+1) 289 514 5100 or (+1) 800 717 1738 or via web http://momentum.adobeconnect.com/greenfirstq120.
...keep reeding on businesswire.com
Marcus Corporation Reports First Quarter Fiscal 2026 Results
MILWAUKEE--(BUSINESS WIRE)--The Marcus Corporation (NYSE: MCS) today reported results for the first quarter fiscal 2026 ended March 31, 2026. “Both Marcus Theatres and Marcus Hotels & Resorts significantly outperformed their respective industries during the first quarter of fiscal 2026,” said Gregory S. Marcus, chief executive officer of Marcus Corporation. “Fueled by a robust film slate that included Project Hail Mary, the first tentpole success of the year, as well as strong carry-over of.
...keep reeding on businesswire.com
3 Unstoppable Growth Stocks For Years Of Passive Income
Passive income separates a paycheck from a portfolio. Earned income stops when you stop working, but dividends landing quarterly do not.
...keep reeding on 247wallst.com
$1 Trillion in AI Capex Is Coming. Here Are 5 Stocks That Will Feast on the Buildout
Like many investors, I enjoy old Buffett videos for their lessons, but also for the quaint numbers of the past.
...keep reeding on 247wallst.com
Solid price gains for gold, silver as USDX solidly down
Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.
...keep reeding on kitco.com
ZOZO, Inc. (SRTTY) Q4 2026 Earnings Call Transcript
ZOZO, Inc. (SRTTY) Q4 2026 Earnings Call Transcript
...keep reeding on seekingalpha.com
Cardinal Health Lifts Outlook Again as Revenue Rises
Cardinal Health once again raised its full-year outlook after logging higher-than-expected adjusted earnings in the third quarter.
...keep reeding on wsj.com
Italy's Dolomiti Energia picks Intesa, Goldman Sachs to lead potential IPO, sources say
Italian regional utility Dolomiti Energia has lined up banks for an initial public offering (IPO) later this year that could value the group at more than 3 billion euros ($3.50 billion), two sources familiar with the matter told Reuters.
...keep reeding on reuters.com
Xtract One Selected to Support School Safety Across Granville County Public Schools
TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its Xtract One Gateway (“Gateway”) system has been selected by Granville County Public Schools in Oxford, North Carolina to strengthen security while minimizing ingress delays and reducing the need for manual bag checks. The initial deployment will take place at two of the district's high schools and support Granville County Public Schools' broader commitment to enhancing safety while maintaining a welcoming learning environment.
...keep reeding on globenewswire.com
OGE Energy unit to power three new Google data centers in Oklahoma
OG&E, a unit of OGE Energy , said on Thursday it will supply electricity to three new Google data centers in Oklahoma announced last year to support grid stability.
...keep reeding on reuters.com
ConocoPhillips Earnings Beat Expectations. Why the Stock Is Falling.
ConocoPhillips earnings were ahead of analysts' forecasts but it expects slightly lower production in the current quarter.
...keep reeding on barrons.com
Textron to Separate Industrial Arm in Shift to Aerospace Focus
The Providence, R.I., company said Thursday it will explore options for the industrial unit, including a potential sale or tax-free spinoff into a publicly traded company.
...keep reeding on wsj.com
Tesla Hits a Milestone With Semi Truck Production. The Stock Edges Higher.
Tesla tweets a picture of its first semi truck built on its high volume assembly line.
...keep reeding on barrons.com
DTE Energy misses quarterly profit estimates as energy trading unit swings to loss
U.S. Midwest utility DTE Energy missed Wall Street estimates for first-quarter profit on Thursday, as a swing to a loss in its energy trading business offset stronger earnings from its electric utility unit.
...keep reeding on reuters.com
Blue Owl Distributable Earnings Rise, Revenue Climbs
Blue Owl Capital's first-quarter distributable earnings climbed as the asset manager logged higher revenue and grew its assets under management.
...keep reeding on wsj.com
Royal Caribbean Cuts Guidance on Rising Fuel Costs. Why the Stock Is Surging.
The cruise operator beat earnings estimates in the first quarter but cut its annual profit forecast amid rising fuel costs.
...keep reeding on barrons.com
Wayfair Narrows Loss but Notes ‘Choppy' Year for Furniture
Wayfair narrowed its loss in the first quarter, but said the year has been tough on the furniture industry so far.
...keep reeding on wsj.com
Schneider Electric S.E. (SBGSY) Q1 2026 Sales/Trading Call Transcript
Schneider Electric S.E. (SBGSY) Q1 2026 Sales/Trading Call Transcript
...keep reeding on seekingalpha.com
archTIS Limited (ARHLF) Q3 2026 Earnings Call Transcript
archTIS Limited (ARHLF) Q3 2026 Earnings Call Transcript
...keep reeding on seekingalpha.com
Bank Polska Kasa Opieki (BKPKF) Q1 2026 Earnings Call Transcript
Bank Polska Kasa Opieki (BKPKF) Q1 2026 Earnings Call Transcript
...keep reeding on seekingalpha.com
Red Light Holland Completes Acquisition of Filament Health, Creating a Global Leader in Psychedelic Drug Development, Commercialization and Distribution
Establishes a vertically integrated platform spanning pharmaceutical-grade botanical drug development and global consumer distribution Adds Filament's extensive intellectual property portfolio, including 70+ patents and proprietary extraction technologies Leverages Health Canada Dealer's License and FDA-aligned clinical development pathways, including IND-enabled activities Positions the Company at the forefront of the rapidly emerging regulated psychedelic medicine industry Advances clinical pipeline, including PEX010, while expanding access to natural psilocybin products globally Establishes a regulated pipeline of psychedelic compounds, including ibogaine, MDMA, and psilocybin, supporting next-generation drug discovery and IND-enabled clinical development within compliant frameworks Toronto, Ontario--(Newsfile Corp. - April 30, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") and Filament Health Corp. (OTC: FLHLF) ("Filament") are pleased to announce, further to their joint press releases dated March 10, 2026 (the "March 10 Release"), March 23, 2026, April 27, 2026 and April 29, 2026, that effective April 29, 2026, Red Light has acquired all the issued and outstanding common shares of Filament ("Filament Shares"), pursuant to a statutory plan of arrangement (the "Arrangement" or the "Transaction") under the Business Corporations Act (British Columbia). Capitalized terms not otherwise defined herein have the meanings attributed to them in the March 10 Release.
...keep reeding on newsfilecorp.com
DT Midstream Reports Strong First Quarter 2026 Results
DETROIT, April 30, 2026 (GLOBE NEWSWIRE) -- DT Midstream, Inc. (NYSE: DTM) today announced first quarter 2026 reported net income of $130 million, or $1.27 per diluted share. For the first quarter of 2026, Operating Earnings were $130 million, or $1.27 per diluted share. Adjusted EBITDA for the quarter was $308 million.
...keep reeding on globenewswire.com
Organon Reports Results for the First Quarter Ended March 31, 2026
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN) today announced its results for the first quarter ended March 31, 2026. First Quarter 2026 Revenue in $ millions Q1 2026 Q1 2025 VPY VPY ex-FX Women's Health $ 389 $ 463 (16)% (19)% General Medicines Biosimilars 173 141 23% 21% Established Brands 880 887 (1)% (7)% Other (1) 18 22 (15)% (21)% Revenue $ 1,460 $ 1,513 (4)% (9)% Totals may not foot due to rounding.
...keep reeding on businesswire.com
Verastem Oncology Launches HCP and Patient Reimagine Campaign to Increase Awareness of AVMAPKI® FAKZYNJA® CO-PACK for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced the launch of its Reimagine Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) campaign for AVMAPKI® FAKZYNJA® CO-PACK (avutometinib capsules; defactinib tablets), the first and only treatment specifically approved by the U.S. Food and Drug Administration (FDA) for adult patients with KRAS-mutated recurrent.
...keep reeding on businesswire.com
Glow Lifetech Expands Distribution with Two of Canada's Largest Cannabis Retailers, Launches New Product Innovation and Advances National Growth Strategy
Toronto, Ontario--(Newsfile Corp. - April 30, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to provide a commercial update highlighting continued expansion of its retail distribution network, new product innovation, and progress advancing its national growth strategy. MOD™ Expands into Two of Canada's Largest Cannabis Retailers Building on Glow's recent success expanding distribution with Canada's leading national cannabis retailers, Glow has expanded distribution of its flagship MOD™ brand into two of Canada's largest cannabis retailers, adding approximately 140 new retail locations across Ontario.
...keep reeding on newsfilecorp.com
Laureate Education Reports Financial Results for the First Quarter of 2026
Company Increases Full-Year 2026 Adjusted Earnings Per Share Guidance Company Increases Full-Year 2026 Adjusted Earnings Per Share Guidance
...keep reeding on globenewswire.com
Chipotle Is Becoming A Less Profitable, Less Appealing Business
Chipotle remains under pressure despite a mild post-earnings bounce, as comp sales returned to flat year-over-year growth. CMG has declined ~10% YTD and ~35% over twelve months, reflecting persistent concerns over its growth trajectory and valuation. I reiterate a sell rating, citing continued rich valuation multiples amid fundamental underperformance and lackluster recovery efforts.
...keep reeding on seekingalpha.com
Allied Critical Metals Establishes "Social Monitoring and Advisory Committee of the Borralha Mine Project"
Vancouver, British Columbia--(Newsfile Corp. - April 30, 2026) - Allied Critical Metals Inc. (CSE: ACM) (OTCQB: ACMIF) (FSE: 0VJ0) ("ACM" or the "Company") announces that Minerália - Minas, Geotecnia e Cosntruções, Lda. ("Minerália") has, as registered title holder of the Borralha mineral concession being held beneficially in trust for ACM, formally established the "Social Monitoring and Advisory Committee of the Borralha Mine Project" (Comissão de Acompanhamento e Observatório Social do Projeto da Mina da Borralha) as a dedicated platform for stakeholder engagement, transparency, and community participation (the "Committee").
...keep reeding on newsfilecorp.com
SIGA to Host Business Update Call on May 7, 2026, Following Release of First-Quarter 2026 Financial Results
NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, May 7, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer.
...keep reeding on globenewswire.com
Fortive Reports First Quarter 2026 Results
EVERETT, Wash.--(BUSINESS WIRE)--Fortive Corporation (“Fortive”) (NYSE: FTV) today announced financial results for the first quarter of 2026. “Q1 represented a strong start to the year and another quarter of solid execution by our team. We delivered core revenue growth of ~5%, adjusted EBITDA growth of ~13%, and adjusted EPS growth of ~25%. This solid performance reflects underlying strength in demand for our market-leading products, encouraging progress in the execution of our Fortive Accelera.
...keep reeding on businesswire.com
JLL Reports Financial Results for First-Quarter 2026
JLL achieved a record first-quarter diluted earnings per share of $3.33, up 207% versus the prior-year quarter (in local currency1) CHICAGO, April 30, 2026 /PRNewswire/ -- Jones Lang LaSalle Incorporated (NYSE: JLL) today reported operating performance for the first quarter of 2026. Diluted earnings per share was $3.33, up 192% in USD and 207% in local currency (LC), and adjusted diluted earnings per share1 was $3.43, up 48% in USD and 56% in LC.
...keep reeding on prnewswire.com
Yuanbao Inc. Files its Annual Report on Form 20-F for Fiscal Year 2025
BEIJING, April 30, 2026 (GLOBE NEWSWIRE) -- Yuanbao Inc. (“Yuanbao” or the “Company”) (NASDAQ: YB), a leading technology-driven online insurance distributor in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission (“SEC”) on April 30, 2026. The annual report can be accessed on the Company's investor relations website at ir.yb-inc.com.
...keep reeding on globenewswire.com
Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical
SAN DIEGO and TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC: APTOF) announced today that closing of the previously announced arrangement (the “Arrangement”) with Hanmi Pharmaceutical Co. Ltd. (“Hanmi”) and HS North America Ltd.
...keep reeding on globenewswire.com
BridgeBio to Report First Quarter 2026 Financial Results and Commercial Updates on May 7, 2026 at 4:30 pm ET
PALO ALTO, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today announced that it will release its first quarter 2026 financial results and business update after the market closes on Thursday, May 7, 2026. BridgeBio will host a conference call to discuss the financial results and program updates at 4:30 pm ET the same day.
...keep reeding on globenewswire.com
ATI Announces First Quarter 2026 Results
Margin expansion and aerospace demand drive double-digit earnings growth GAAP EPS up 27% year-over-year; Operating cash flow up $221 million Adjusted EBITDA margin 20.1%, up 310 bps. year-over-year Raising full year adjusted earnings and cash flow guidance First Quarter 2026 GAAP Financial Results Sales of $1.15 billion, up 1% year-over-year, driven by a 6% aerospace & defense increase Net income attributable to ATI of $118 million, up 22% year-over-year Earnings per share of $0.85 compared to $0.67 per share in first quarter 2025 First Quarter 2026 Non-GAAP Financial Information (a) Adjusted net income attributable to ATI(a) of $139 million, up 33% year-over-year Adjusted earnings per share(a) of $1.00, compared to $0.72 per share in first quarter 2025 Adjusted EBITDA(a) of $232 million, an increase of 19% year-over-year Adjusted EBITDA(a) as a percentage of sales of 20.1%, compared to 17.0% in first quarter 2025 Guidance The Company is providing second quarter and updated, full year 2026 guidance in the table below.
...keep reeding on prnewswire.com
Medicenna and Fondazione Melanoma Onlus Announce Presentation on NEOCYT Trial at ASCO 2026
TORONTO and HOUSTON, April 30, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company developing Superkines for targeting cancer and autoimmune disease, today announced the presentation of a poster on the NEOCYT Trial at the upcoming Annual Meeting of the American Society of Clinical Oncology to be held in Chicago from May 29th to June 3rd, 2026. The clinical trial is a randomized, investigator‑initiated neoadjuvant Phase 1b trial testing MDNA11, a long‑acting, “beta‑enhanced not‑alpha” IL‑2 Superkine, in combination with nivolumab (anti‑PD‑1) with or without ipilimumab (anti‑CTLA‑4) for patients with high‑risk, surgically resectable Stage III cutaneous melanoma.
...keep reeding on globenewswire.com